CPAP for Esophageal Cancer With Radiotherapy - Trial NCT06037902
Access comprehensive clinical trial information for NCT06037902 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheba Medical Center and is currently Recruiting. The study focuses on Esophageal Cancer. Target enrollment is 44 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sheba Medical Center
Timeline & Enrollment
N/A
Aug 21, 2023
Sep 30, 2027
Primary Outcome
absolute mean heart radiation dose
Summary
The goal of this clinical trial is to test the use of CPAP in patients with esophgaeal cancer
 undergoing radiotherapy.
 
 The main questions it aims to answer are:
 
 - does use of CPAP decrease exposure of normal lung to radiation?
 
 - does use of CPAP decrease exposure of normal heart to radiation?
 
 Participants will undergo simulation twice:
 
 - with CPAP
 
 - without CPAP
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06037902
Device Trial